Solomon Epstein

5.4k total citations · 1 hit paper
72 papers, 3.7k citations indexed

About

Solomon Epstein is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Solomon Epstein has authored 72 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Orthopedics and Sports Medicine, 35 papers in Molecular Biology and 31 papers in Oncology. Recurrent topics in Solomon Epstein's work include Bone health and treatments (29 papers), Bone Metabolism and Diseases (23 papers) and Bone and Joint Diseases (21 papers). Solomon Epstein is often cited by papers focused on Bone health and treatments (29 papers), Bone Metabolism and Diseases (23 papers) and Bone and Joint Diseases (21 papers). Solomon Epstein collaborates with scholars based in United States, United Kingdom and Canada. Solomon Epstein's co-authors include James D. Lewis, Yu‐Xiao Yang, David C. Metz, C. Conrad Johnston, Mone Zaidi, Angela M. Inzerillo, Richard Aguilar, Stanley S. Schwartz, Struan F.A. Grant and Barbara E. Corkey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Solomon Epstein

71 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture

2006 914 citations Yu‐Xiao Yang, James D. Lewis et al. JAMA profile →

Peers

Countries citing papers authored by Solomon Epstein

Since Specialization

Citations

This map shows the geographic impact of Solomon Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solomon Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solomon Epstein more than expected).

Fields of papers citing papers by Solomon Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solomon Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solomon Epstein. The network helps show where Solomon Epstein may publish in the future.

Co-authorship network of co-authors of Solomon Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Solomon Epstein. A scholar is included among the top collaborators of Solomon Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solomon Epstein. Solomon Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Unified Pathophysiological Construct of Diabetes and its Complications 2017 ·Trends in Endocrinology and Metabolism ·Stanley S. Schwartz, Solomon Epstein, Barbara E. Corkey, Struan F.A. Grant, James R. Gavin, Richard Aguilar, Mary E. Herman	81
2	Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss 2009 ·Current Osteoporosis Reports ·Mone Zaidi, Charles H. Turner, Ernesto Canalis, Roberto Pacifici, Li Sun, Jameel Iqbal, (unknown), Stuart Silverman, Solomon Epstein, Clifford J. Rosen	39
3	Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study 2009 ·Clinical Therapeutics ·Ronald Emkey, Pierre D. Delmas, Michael A. Bolognese, João Lindolfo Cunha Borges, Felicia Cosman, Sergio Ragi-Eis, Christopher Recknor, Cristiano A. F. Zerbini, (unknown), Farhad Sedarati, Solomon Epstein	26
4	Evaluating the Antifracture Efficacy of Bisphosphonates 2009 ·Reviews on Recent Clinical Trials ·Michael Pazianas, Solomon Epstein, Mone Zaidi	16
5	Progression of Efficacy with Ibandronate 2007 ·Annals of the New York Academy of Sciences ·Mone Zaidi, Solomon Epstein, Steven T. Harris, Joseph D. Kohles, Charles H. Chesnut	11
6	Is treatment of early postmenopausal women with bisphosphonates justified? 2007 ·International Journal of Clinical Practice ·Solomon Epstein	3
7	Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture breakdown → 2006 ·JAMA ·Yu‐Xiao Yang, James D. Lewis, Solomon Epstein, David C. Metz	914
8	Modeling of Serum C‐Telopeptide Levels with Daily and Monthly Oral Ibandronate in Humans 2006 ·Annals of the New York Academy of Sciences ·Mone Zaidi, Solomon Epstein, Keith Friend	7
9	Biological properties and mechanism of action of ibandronate: Application to the treatment of osteoporosis 2005 ·Bone ·Solomon Epstein, Mone Zaidi	20
10	Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus 2005 ·Transplant International ·Josep M. Campistol, David W. Holt, Solomon Epstein, Martine Gioud-Paquet, Karine Rutault, James T. Burke, (unknown)	42
11	Osteoporosis and Diabetes Mellitus 2004 ·Reviews in Endocrine and Metabolic Disorders ·Angela M. Inzerillo, Solomon Epstein	80
12	Ibandronate: A Clinical Pharmacological and Pharmacokinetic Update 2004 ·The Journal of Clinical Pharmacology ·Joanne Barrett, E. Worth, Frieder Bauss, Solomon Epstein	123
13	A new function for CD38/ADP-ribosyl cyclase in nuclear Ca2+ homeostasis 1999 ·Nature Cell Biology ·(unknown), (unknown), (unknown), (unknown), Gopa Biswas, Lei Sun, (unknown), (unknown), (unknown), Solomon Epstein, F. Anthony Lai, (unknown), Mone Zaidi	139
14	Molecular and Functional Evidence for Calcineurin-A α and β Isoforms in the Osteoclast: Novel Insights into Cyclosporin A Action on Bone Resorption 1999 ·Biochemical and Biophysical Research Communications ·Emmanuel M. Awumey, Baljit S. Moonga, Bali R. Sodam, (unknown), Olugbenga A. Adebanjo, Masayoshi Kumegawa, Mone Zaidi, Solomon Epstein	38
15	Immunosuppressive therapy and the skeleton 1994 ·Trends in Endocrinology and Metabolism ·E Shane, Solomon Epstein	16
16	Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. 1994 ·Endocrinology ·Gary N. Mann, Thomas Jacobs, Farrel J. Buchinsky, (unknown), (unknown), H.Z. Ke, Yunfei Ma, W.S.S. Jee, Solomon Epstein	56
17	Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management 1991 ·Seminars in Arthritis and Rheumatism ·Ian I. Joffe, Solomon Epstein	79
18	Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone 1990 ·Journal of Orthopaedic Research® ·Colin Movsowitz, (unknown), Solomon Epstein, Firhaad Ismail, M D Fallon, S. Thomas	42
19	Demonstration of reduced mitogenic and osteoinductive activities in demineralized allogeneic bone matrix from vitamin D-deficient rats. 1988 ·Journal of Clinical Investigation ·Russell T. Turner, Jonathan Farley, Jacob J. Vandersteenhoven, Solomon Epstein, Norman H. Bell, D J Baylink	21
20	Bone Mineral Metabolism in Experimental Diabetes Mellitus: Osteocalcin as a Measure of Bone Remodeling 1988 ·Endocrinology ·Neville Glajchen, Solomon Epstein, Firhaad Ismail, S. Thomas, M D Fallon, Subrata Chakrabarti	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact